DNK-333

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameDNK-333
Drug Alias NameDNK-333ADNK-333
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonistsNeurokinin 2 receptor antagonists
TargetsNeurokinin 2 receptorNeurokinin 1 receptor
Therapy Area/IndicationsDermatitis, AtopicPulmonary Disease, Chronic ObstructiveIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNetherlands +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicPulmonary Disease, Chronic ObstructiveIrritable Bowel Syndrome

Other Information

ATC CodeN/A
Related LinksN/A